California Life Sciences (CLS) finalized its program for the Cell and Gene Therapy Symposium.
Public source
Publisher name
Public post
Cell and gene therapies have already reshaped the ways we think about and treat some of the toughest diseases. But what new advancements, industry trends, and ethical co…
Company
California Life Sciences (CLS)
California Life Sciences (CLS) is the state’s most influential and impactful life sciences membership organization.
- Industry
- Non-profit Organizations
- Location
- South San Francisco, US
- Company size
- 51–200 employees
About California Life Sciences (CLS)
California Life Sciences (CLS) is the state’s most impactful life sciences membership organization, advocating for the sector and its diverse innovation pipeline. For more than 30 years, CLS has served the community by supporting companies of all sizes, from early-stage innovators and startups to established industry leaders in the fields of biotechnology, pharmaceuticals, and medical technology. As integral components of a healthy and collaborative ecosystem, CLS also works closely with universities, academic and research institutions, the investment community, and other critical partners that promote this vibrant sector. With offices in South San Francisco, San Diego, Sacramento, Los Angeles, and Washington DC, CLS works to shape public policy, improve access to breakthrough technologies, educate lawmakers, and advance equity within our ecosystem by championing innovative solutions for some of the most pressing challenges of our times. In doing so, CLS fulfills its mission to protect and nurture California’s life sciences industry, empowering discoveries that lead to healthier lives around the world. #WeAreCaliforniaLifeSciences
See moreLatest activity
Latest activity from California Life Sciences (CLS)
19 signals
People
California Life Sciences (CLS) welcomed Joy Russell and Sarah Huoh as Chair and Vice Chair of the Board of Directors.
People
California Life Sciences (CLS) welcomed 12 new members last month, including 4basebio, Aurora Microplates, BioDuro, Harrens Lab Inc., Hinge Bio, Inixi Bio, Marigold Biosciences, Melody FRO, LLC, MRIGlobal, PrecisionMHC, Solvias, and Until.
Products & Services
California Life Sciences (CLS) announced that Casgevy, approved in 2023 for sickle cell disease, uses CRISPR to edit a patient's own blood stem cells outside the body, returning them both cell and gene therapy at once.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy is attending the 2026 Policy Summit, which is less than one week away.
Presence & Recognition
SLAS (Society for Laboratory Automation and Screening)
SLAS (Society for Laboratory Automation and Screening) announced that September 14, 2026, is the final day to submit research for the opportunity to present, win podium-related awards, or showcase startups at the next year's conference in San Diego, California.
Presence & Recognition
n-Lorem Foundation
n-Lorem Foundation presented Dr. Julie Douville on how the company built an efficient and flexible preclinical development model to deliver individualized ASO medicines to nano-rare patients.
Presence & Recognition
BioscienceLA
BioscienceLA is hosting the BioscienceLA Week Economic Summit in Los Angeles with new tools and resources debut alongside top leaders.
Presence & Recognition
Women In Bio - Engage. Educate. Empower.